Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2026 is 16.24% vs 5.43% in Sep 2025
Consolidate Net Profit
YoY Growth in quarter ended Sep 2026 is 27.72% vs 82.88% in Sep 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2026 is 68.22% vs -2.82% in Sep 2025
Interest
YoY Growth in quarter ended Sep 2026 is 70.71% vs -4.81% in Sep 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2026 has improved from Sep 2025
Compare Quarterly Results Of Medicamen Biotec With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2026 is 14.47% vs -21.02% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 16.24% vs 5.43% in Sep 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2026 is 60.85% vs -45.08% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 27.72% vs 82.88% in Sep 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2026 is 100.46% vs -20.40% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 68.22% vs -2.82% in Sep 2025
Quarterly - Interest
QoQ Growth in quarter ended Sep 2026 is 103.61% vs 118.42% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 70.71% vs -4.81% in Sep 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026
YoY Growth in quarter ended Sep 2026 has improved from Sep 2025